institute for cancer research

Volume 5	News for Patients, Caregivers and Physicians		2002
Oncologist Education Campaign
Because the face of medicine is ever growing and changing, we’ve also decided to take the initiative and begin helping the over 13,000 practicing oncologists nationwide learn about the latest scientifically proven research on promising integrative bio-nutritional protocols for the treatment of cancer. This newsletter below will be sent to all Oncologists.
Oncology “Integrative” Newsletter Vol 6;02 · Evidence Based Oncology · 1 Page Fax University of Chicago University of Iowa Physicians Advisory Board to the US Congress   Yale Hospital New England Journal of Medicine
Numerous studies published over the past several years support the concept that what is considered good nutrition can actually fuel growth in most cancers – and that diets deprived of certain amino acids, and carbohydrates can cause cancerous tumors to stop growing, regress and often disappear. Dr. Albert B. Lorincz of the University of Chicago conducted a trial with several advanced cancer patients, reducing tumor size in most of them who were fed a formula restricted in certain amino acids, a treatment similar to the one pioneered by the A.P. John Institute for Cancer Research called Controlled Amino Acid Therapy (CAAT).  And in numerous published studies, Dr. Douglas Spitz of the University of Iowa, and other researchers reported how carbohydrate deprivation, another part of the CAAT protocol, kills cancer cells while having no effect on normal cells. In February 2002, at the Yale Cancer Center of Yale-New Haven Hospital, Dr. Joel Evans, Honorary Co-Chairman of the Physicians advisory Board to the U.S. Congress, lectured on cancer and nutrition, discussing Controlled Amino Acid Therapy and citing a notable recovery a patient of his experienced since using CAAT. Also, in the January 2002 edition of The New England Journal Of Medicine, in a piece entitled “Lung Cancer – Time to Move		on From Chemotherapy,” Dr. Desmond N. Carney of Mater Misericordiae Hospital in Dublin, Ireland, concluded that the use of specific biologic targets, the strategy employed by CAAT, offers “…optimism and  hope that mortality from this disease may be reduced.” CAAT works synergistically with and enhances chemotherapy and/or radiation to arrest the growth of tumors and cause them to regress by altering or impairing the development of cancer cells.  CAAT has also been proven to be effective alone. Today, more and more doctors are employing bio-nutritional therapies in treating diseases.  Hematologists are using vitamin B-12 to treat pernicious anemia; immunologists are putting tuberculosis patients on high-protein diets; cardiologists know vitamin E helps patients after bypass surgery.  And now, oncologists are discovering the benefits of CAAT. For questions about the A.P. John Institute for Cancer Research, how CAAT works, physician information, or anything else you may wish to discuss, please call us toll-free at 877-661-2228 or e-mail us at apjohninstitute@aol.com. You can also obtain information about us by visiting our website at www.apjohncancerinstitute.org

Do you know a friend who would like this newsletter. Share it today!